<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
   <TITLE>Docetaxel - the new taxoid</TITLE>
   <META NAME="Author" CONTENT="Karne">
   <META NAME="GENERATOR" CONTENT="Mozilla/3.04Gold (Win16; I) [Netscape]">
   <META NAME="Description" CONTENT="A new form of Taxoid and the synthesis of it.A new Taxoid and it's synthesis">
</HEAD>
<BODY TEXT="#000000" BGCOLOR="#FFFFFF" LINK="#03EF6D" VLINK="#E1340F" ALINK="#FF0000" BACKGROUND="bnd_wire.gif" style="background-repeat: repeat-y;">

<UL>
<UL>
<H1 ALIGN=CENTER><FONT COLOR="#000000">Taxol<SUP><FONT SIZE=+1>®</FONT></SUP>
and Related Anticancer Drugs</FONT></H1>
</UL>
</UL>

<UL>
<UL>
<H2><FONT COLOR="#000080">Docetaxel - the new taxoid</FONT></H2>

<DIV ALIGN=right><P><IMG USEMAP="#docetax" SRC="docetax.gif" ALT="Docetaxel Struture" HEIGHT=191 WIDTH=395 ALIGN=RIGHT BORDER=0>
<MAP NAME="docetax"><AREA SHAPE="RECT" ALT="" COORDS="266,5,310,33" HREF="ref.html#def21" TARGET="ref" ONMOUSEOVER="window.status='Functional Group';return true" ONMOUSEOUT="window.status=' '"><AREA SHAPE="RECT" ALT="" COORDS="11,46,68,108" HREF="ref.html#def21" TARGET="ref" ONMOUSEOVER="window.status='Functional Group';return true" ONMOUSEOUT="window.status=' '"><AREA SHAPE="RECT" ALT="" COORDS="64,122,193,165" HREF="ref.html#def22" TARGET="ref" ONMOUSEOVER="window.status='Docetaxel is marketed as Taxotere';return true" ONMOUSEOUT="window.status=' '"><AREA SHAPE="DEFAULT" HREF="ref.html#def21" TARGET="ref" ONMOUSEOVER="window.status='The Basic Structure of Docletaxel is identical to Pacliaxel';return true" ONMOUSEOUT="window.status=' '"></MAP></P></DIV>

<P><FONT SIZE=+1>A promising alternative to Paclitaxel is <B><A HREF="ref.html#def22" TARGET="ref" ONMOUSEOVER="window.status='Docetaxel is margeted as Taxotere';return true" ONMOUSEOUT="window.status=' '">Docetaxel
</A></B>(<I>Taxotere</I></FONT><I><SUP><FONT COLOR="#000000"><FONT SIZE=-1>®</FONT></FONT></SUP></I><FONT SIZE=+1>),
a very similar chemical analogue. It was developed in the early 1980s by
the French pharmaceutical firm <B>Rhone-Poulene Rorer</B>, who were researching
the semi synthetic form of Paclitaxel at the time (see <A HREF="semisyn.html" TARGET="main" ONMOUSEOVER="window.status='Semi Synthesis of Taxol';return true" ONMOUSEOUT="window.status=' '">Semi
Synthesis of Taxol</A>). Indeed, <B>Docetaxel </B>is made in a very similar
manner - being based on the same <B>10-deacetylbaccatin III</B> (<A HREF="ref.html#def23" TARGET="ref" ONMOUSEOVER="window.status='Biologically inactive';return true" ONMOUSEOUT="window.status=' '">noncytotoxic</A>)
precursor, extracted from yew needles and stems. This core is then esterified
with the addition of a sidechain in a similar manner to Paclitaxel. However
it has shown to be over two and a half times as effective an anticancer
agent as Paclitaxel, at equitoxic doses. Preclinical trials have shown
<I>in</I> <I>vitro </I>activity against colon cancer and B16 melanoma.
As a result of this work, phase I clinical studies were initiated in 1990.</FONT><SUP><FONT SIZE=-1><A HREF="ref.html#bib6" TARGET="ref" ONMOUSEOVER="window.status='OncoLink';return true" ONMOUSEOUT="window.status=' '">(6)</A></FONT></SUP></P>

<P><FONT SIZE=+1>Docetaxel has a molecular weight of <B>808 </B>g/mol</FONT><SUP><FONT SIZE=-1>-1</FONT></SUP><FONT SIZE=+1>
and like Paclitaxel, is almost insoluble in water. It is however freely
soluble in a mixture of <I>dimethylformamide, 95% v/v ethanol, 0.1 M sodium
hydroxide and methanol.</I> Both drugs consist of a 4-ring core linked
to an ester sidechain, at position <B>C13</B>. The main structural differences
are a deacylation at <B>C10 </B>and the functional group on the end of
the sidechain.</FONT><SUP><FONT SIZE=-1><A HREF="ref.html#bib11" TARGET="ref" ONMOUSEOVER="window.status='Cyberbotanica';return true" ONMOUSEOUT="window.status=' '">(11)</A></FONT></SUP></P>

<CENTER><TABLE CELLSPACING=0 CELLPADDING=0 WIDTH="75%" >
<TR>
<TD ALIGN=CENTER VALIGN=CENTER><EMBED SRC="http://cmm.info.nih.gov/modeling/drugbank/compounds/structures/taxol.pdb" WIDTH=250 HEIGHT=250 border=0 name="Paclitaxel" frank=no  spiny=18 startspin=true display3d=spacefill  bgcolor="#FFFFFF" alt="Sorry, you need the Chime plugin."></EMBED></TD>

<TD ALIGN=CENTER VALIGN=CENTER><EMBED SRC="http://cmm.info.nih.gov/modeling/drugbank/compounds/structures/taxotere.pdb" WIDTH=250 HEIGHT=250 border=0 name="Docetaxel" frank=no spiny=18 startspin=true display3d=spacefill  bgcolor="#FFFFFF" alt="Sorry, you need the Chime plugin."></EMBED></TD>
</TR>

<TR>
<TD ALIGN=CENTER VALIGN=CENTER>
<CENTER><P><B><FONT COLOR="#000080"><FONT SIZE=+2>Paclitaxel</FONT></FONT></B></P></CENTER>
</TD>

<TD ALIGN=CENTER VALIGN=CENTER>
<CENTER><P><B><FONT COLOR="#000080"><FONT SIZE=+2>Docetaxel</FONT></FONT></B></P></CENTER>
</TD>
</TR>
</TABLE></CENTER>

<P><FONT COLOR="#0000A0"><FONT SIZE=-1>[This needs the <A HREF="ref.html#def10" TARGET="ref" ONMOUSEOVER="window.status='Chime Plugin';return true" ONMOUSEOUT="window.status=' '">Chime
</A>plugin. The 3D molecule is active; <B>left click </B>on it, to move
it around and <B>right click</B> to trigger a menu]</FONT></FONT></P>

<CENTER><P><FONT SIZE=+1><FONT COLOR="#0000A0"><B>Suggestion - </B>try
changing to<B> </B></FONT><B><FONT COLOR="#000000">Display = Wireframe</FONT><FONT COLOR="#0000A0">
</FONT></B><FONT COLOR="#0000A0">if you can't see the differance.</FONT></FONT></P></CENTER>

<P><FONT SIZE=+1>The biological effects of Docetaxel are pretty much identical
to those of Paclitaxel - acting by stabilising microtubules. However, it’s
greater effectiveness suggests that it’s bonding to the filament is stronger
- it has a greater affinity for microtubules than Paclitaxel. In addition,
trials have shown that those treated with Docetaxel have a significantly
lower incidence of <B>hypersensitivity </B>(see <A HREF="bio.html" TARGET="main" ONMOUSEOVER="window.status='Biological Effects';return true" ONMOUSEOUT="window.status=' '">Biological
Effects</A>) - a major problem with Paclitaxel, meaning that patients must
take premeditation. However, like Paclitaxel this drug still has a serious
toxicity problem.</FONT></P>

<P><FONT SIZE=+1>Docetaxel is available from <B>Rhone-Poulene Rorer </B>as
an investigational agent. The drug (80 mg) is dissolved in polysorbate
80. </FONT></P>

<P>
<HR WIDTH="100%"></P>

<CENTER><P><A HREF="ref.html#defic" TARGET="ref" ONMOUSEOVER="window.status='Imperial College crest';return true" ONMOUSEOUT="window.status=' '"><IMG SRC="chcr_tn.gif" ALT="Imperial College crest" BORDER=0 HEIGHT=62 WIDTH=60 ALIGN=CENTER></A><FONT SIZE=+1>Next
Page: <A HREF="syn.html" TARGET="main" ONMOUSEOVER="window.status='Synthesis of Taxol - from scatch';return true" ONMOUSEOUT="window.status=' '">Synthesis of Taxol</A> - <I>from scratch</I></FONT><A HREF="ref.html#defic" TARGET="ref" ONMOUSEOVER="window.status='Imperial College crest';return true" ONMOUSEOUT="window.status=' '"><IMG SRC="chcr_tn.gif" ALT="Imperial College crest" BORDER=0 HEIGHT=62 WIDTH=60 ALIGN=CENTER></A></P></CENTER>

<P>
<HR WIDTH="100%"></P>
<CENTER>
<B>

</UL>
</UL>

</BODY>
</HTML>
